Chargement en cours...

n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial

BACKGROUND AND PURPOSE: Liquid n-butyl cyanoacrylate (n-BCA) use for the treatment of arteriovenous malformations (AVM) in the brain has become part of medical practice. However, no study has led to the Food and Drug Administration’s approval of n-BCA for intravascular use. The purpose of this study...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AJNR Am J Neuroradiol
Format: Artigo
Langue:Inglês
Publié: American Society of Neuroradiology 2002
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7974739/
https://ncbi.nlm.nih.gov/pubmed/12006271
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!